iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
5 hedge funds and large institutions have $2.26M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
46% less capital invested
Capital invested by funds: $4.21M → $2.26M (-$1.95M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.74M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$24.8K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
-$24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $1.7M | -$1.74M | -70,000 | -50% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $468K | +$10.4K | +421 | +2% |
|
|
AG
3
Advisor Group
Phoenix,
Arizona
| $74K | -$24K | -967 | -24% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $24K | -$24.8K | -1,000 | -50% |
|
IEIH Hedge Fund Activity: Q3 2019 in Review
5 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q3 2019, worth a combined $2.26M — down 46% from $4.21M a quarter earlier.
Fund positioning in IEIH was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $10.4K. The largest seller was BlackRock, cutting an estimated $1.74M.
- 5 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $2.26M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q3 2019, down 46% quarter-over-quarter.
- 0 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q3 2019 and 0 closed out.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q3 2019 was Tower Research Capital (TRC), an estimated $10.4K added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q3 2019 was BlackRock, an estimated $1.74M sold.
Based on aggregated 13F filings for Q3 2019.